View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
DOJ/DEA RIN: 1117-AB31 Publication ID: Spring 2011 
Title: ●Classification of Two Steroids, Prostanozol and Methasterone, as Schedule III Anabolic Steroids under the Controlled Substances Act 
Abstract: This rule classifies the following two steroids as "anabolic steroids" under the Controlled Substances Act (CSA): prostanozol and methasterone. The Drug Enforcement Administration (DEA) believes that this action is necessary to prevent the abuse and trafficking of these steroids. If the regulations are amended, these steroids will be listed as schedule III controlled substances subject to the regulatory control provisions of the CSA. 
Agency: Department of Justice(DOJ)  Priority: Substantive, Nonsignificant 
RIN Status: First time published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: Undetermined  Unfunded Mandates: No 
CFR Citation: 21 CFR 1300   
Legal Authority: 21 USC 802    21 USC 821    21 USC 829    21 USC 871(b)    21 USC 951    21 USC 958(f)   
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  06/00/2011    
NPRM Comment Period End  08/00/2011    
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Agency Contact:
Cathy A. Gallagher
Acting Chief, Liaison and Policy Section
Department of Justice
Drug Enforcement Administration
600 Army Navy Drive,
Arlington, VA 22202
Phone:202 307-7297
Email: cathy.a.gallagher@usdoj.gov